Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19

NCT04469153 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04469153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04469153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Unknown status
Start date
June 29, 2020
Completion date
December 31, 2020
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glycosylated ferritin in sars-cov-2 infection in hospitalized covid-19 patients, the prognostic value of ferritin